Updated / Tuesday, 13 Apr 2021
11:10
Mary Favier stressed that the benefits of the vaccine still outweigh the risks
Covid-19 adviser for the Irish College of General Practitioners and member of National Public Health Emergency Team (NPHET) Dr Mary Favier has said the decision to change the roll-out of the AstraZeneca vaccine is significant and will cause some pause to the vaccination programme.
Dr Favier stressed that the benefits of the vaccine still outweigh the risks, and urged anyone under 60 and in a high risk category who has already received the first jab, to get the second dose.
"People really need to understand that the risk of Covid is still higher than any risk of the vaccine and vaccination is so important to get us out of these restrictions," she added.